U.S. Markets open in 7 hrs, 50 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -0.24 | Current P/E Ratio: | -4.50 |
|---|---|---|---|
| Last Quarter's Earnings: | -0.02 | Current Quarter Estimate: | 0.01 |
| Last Fiscal Year Earnings: | -0.30 | Next Fiscal Year Estimate: | -0.116 |
| Analyst Consensus: | Strong Buy | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation Strong Buy
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 11/16/2009 * | 18:00 | Q3 2009 CytRx Corp. Earnings Release |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 09/14/2009 | CytRx Corp. at Sachs Associates Biotech in Europe Investor Forum | — | — |
| 09/09/2009 | CytRx Corp. at Rodman & Renshaw Annual Global Investment Conference | — | — |
| 08/10/2009 | Q2 2009 CytRx Corp. Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts